AGENDA
DAY 1
Wednesday, 25 September 2024
09h00
Welcome coffee and registration
09h50
Welcome address
10h00
Opening Keynote Lecture
- Descartes Auditorium
Chairman
10h00
Mastering Complexity: Advancing Biotherapeutic Developability in a Standardized Manufacturing Landscape
Cécile GENY
Head of MSAT Global Vaccine
Sanofi, France
10h30
Breakthrough Innovations in Bioproduction - Session I
- Descartes Auditorium
Chairman
10h30
Exploring Bioproduction : Market Dynamics and Innovations
Anabelle PERRIER
Market Research Manager
MabDesign, France
10h40
Artificial Intelligence for operationnal excellence with ROMBIO
Louis DESCHANEL
Business Developer
Rombio, Belgium
10h50
Process Control as a Pillar for IMPD Approval
Guillaume LAY
CCO
Cell-Easy, France
11h00
Cell●Secret●Service Platform Transforms Secretomes from Resolution-Associated Macrophages into Biological Drugs
Sylvain PERRUCHE
CEO
MED’INN’Pharma, France
11h20
Round Table I - Due Diligence in Bioproduction: Legal and Financial Perspectives for Successful Transactions
- Descartes Auditorium
Chairman
10h00
Titre de la présentation
Michael SNEIJERS
Director
Archimed, France
10h00
Titre de la présentation
Charles CORNEVIN
Principal
Lauxera Capital Partners, France
10h00
Titre de la présentation
Alexandre BOULAY
Investment Director
GoCapital, France
10h00
Titre de la présentation
Loïc LEMERCIER
Partner
Dentons, France
12h00
Lunch at the Exhibition Hall
14h00
Parallel Workshops
- Descartes Auditorium
Chairman
10h00
Accelerate biotech process development
Prénom NOM
Fonction
Entreprise, Pays
10h30
Business continuity plan : Don’t forget to secure the storage of your biological resources!
Prénom NOM
Fonction
Entreprise, Pays
10h30
Point-of-need analytics and process analytical technologies: 4 case studies
Prénom NOM
Fonction
Entreprise, Pays
10h30
Journey to Immerscio.bio new trainings through Virtual Reality, Serious Game and Video Workshops
Prénom NOM
Fonction
Entreprise, Pays
15h30
Break
15h40
Biologics Developability - Session I
- Descartes Auditorium
Chairman
15h40
Canonical and complex antibody-based products developability
Alain BECK
Senior Director, Biologics CMC and Developability
Laboratoires Pierre Fabre, France
16h00
Developability assessment of next generation Biotherapeutics
Paul WASSMANN
Senior Principal Scientist
Novartis, Switzerland
16h20
A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization
Stefan ZIELONKA
Global Head of Antibody Discovery & Protein Engineering
Merck Healthcare KGaA, Germany
16h40
VMF: Disruptive & sustainable Vibro® technology for improving bioprocesses yield and environmental footprint
Jarno ROBIN
Pharma Business Development Director
SANI Membranes, Denmark
16h50
Cell sampling ? A critical step to master your upstream bioprocess (USP) monitoring
Joelle EID
Field Application Scientist
GenSensor, France
Analytical Methods
- Pasteur Auditorium
Chairman
15h40
How to accelerate vaccine process development by digitalization and automation: definition of an optimized Workflow for Bioprocess and Analytic laboratories
Stéphanie RICHARD
Analytical Immunology Process Support Unit Manager
Sanofi, France
10h30
Titre de la présentation
Loïc BENAIR
Senior Scientist Drug Substance Development
Sanofi, France
16h00
Leveraging single-cell transcriptomics to tailor insect cells for production of rAAV and influenza HA-VLPs
Antonio ROLDAO
Head of Vaccines Development Lab
iBET, Portugal
16h00
NGS based testing in biosafety: the EFS experience
Delphine GRICOURT
Marketing Director
PathoQuest, France
16h00
Title
Pauline SOUETRE
Quality Control Manager
Etablissement Français du Sang (EFS), France
16h00
Multi-Attribute Analysis of mRNA by LC/MS
Arnaud DELOBEL
R&D and Innovation Director
Quality Assistance, Belgium
16h00
Application of the Ctech FlowVPX online PAT system for real-time monitoring of protein concentration and control of a TFF step
Bérengère FRANÇOIS
EU Bioanalytics Team Lead
Repligen, Europe
Alan DEDUYER
DSP Scientist Drug Substance Development
Sanofi, France
17h00
Coffee Break at the Exhibition Hall
17h40
Biologics Developability - Session II
- Descartes Auditorium
Chairman
17h40
Antibody and Antibody Drug Conjugates Developability
Matthieu CULIE
Head of Monoclonal antibodies industrial process development
GTP Bioways, France
10h30
Titre de la présentation
Hervé GINISTY
CSO
GTP Bioways, France
18h00
Why early mAb Sequence Optimization can Improve Developability and Reduce Costs
François COUTARD
Scientific Director, Head of Cell Line Development, Process & Product Design
Just Evotec Biologics, France
Christophe MARTIN
Senior Director Business Development Europe
Just Evotec Biologics, France
18h20
Optimised Detergents for Upstream to Downstream to Final Fill Finish
James HUMPHREY
Research & Technology Specialist
Croda, UK
18h30
In-line Cell Density Monitoring in Production – Principles and state-of-the-art Sensors
Jochen UHLENKUKEN
Application Specialist Cell Density
Hamilton Bonaduz AG, Switzerland
18h40
Innovative tools to monitor biological variability of bioprocesses
Philip PERROUD
Head of Process Development group
Naobios, France
Anne-Sophie GARY
Principal Scientist
GenSensor, France
18h50
Measure, Understand, Control, Improve… With Process Analytical Technology (PAT)
Michael SACHPEKIDIS
Senior Strategic Account Manager
Optimal Industrial Technologies, UK
Process modeling & Digital twins
- Pasteur Auditorium
Chairman
17h40
Future-Proofing with AI-Powered Bioprocess Development
Belma ALISPAHIC
Chief Scientific Officer
Analysis Mode, Finland
18h00
Genedata E2E Platform for Novel Modality R&D and Machine Learning
Maxime RANTZ
Scientific Consultant
Genedata, Switzerland
18h20
How can process modeling be used to accelerate development? A comparison of the mechanistic, hybrid, AI models
Eric CALVOSA
Senior Project Coordinator & Global Bioprocess Expert
Sanofi, France
19h00
Poster Session at the Exhibition Hall, Wine & Cheese
20h30
End of DAY 1
DAY 2
Thursday, 26 September 2024
08h00
Welcome Coffee
08h30
Sustainable Manufacturing
- Descartes Auditorium
Chairman
10h00
Titre de la présentation
Thibault RENAUD
Global Sustainability Supply Chain Leader
Cytiva, France
10h00
Innovating Sustainability: How Saint-Gobain Bioprocess Solutions, a single-use supplier, is creating more sustainable manufacturing
Caroline CALMELS
Sustainability Market Manager
Saint-Gobain Life Science, France
10h30
How to reach Sustainable Biomanufacturing using Virtual Twins powered by real-world data
Clément GLACE
Life Sciences Manufacturing Solution Leader
Dassault Systèmes, France
10h30
Constellab™ - Unleashing full data potential and next-gen digital twins for more sustainable R&D and manufacturing
Adama OUATTARA
CEO and co-founder
Gencovery, France
Quality & Regulatory
- Pasteur Auditorium
Chairman
10h00
Specific CMC regulatory requirements to fill FIH in China, Taiwan and South Korea for a biological product
Carole LASSERRE
Regulatory Affairs Leader, CMC Pre-MA Expert
Laboratoires Pierre Fabre, France
08h50
ICH Q5A(R2) and its applicability in different countries
Hervé BROLY
ex-VP Biotech Process Development
Merck Serono, Switzerland
10h30
Expediting the Delivery of Innovative Biologics to the Clinic and Beyond
Yucai LI
Vice President of CMC Management, leading Wuxi Biologics European CMC team
WuXi Biologic, Sweden
10h30
Accelerated Quality Control: from Cell Bank characterisation to DS release testing: Regulatory & Technical review
Philippe GRIMM
Business Development & Marketing Director
SGS Vitrology, Scotland
09h40
Round Table II - Empowering Industrial Sustainable Transformation through Collaborative & Digital Solutions
- Descartes Auditorium
Round Table III - Quality & Regulatory
- Pasteur Auditorium
Chairman
10h10
Coffee Break at the Exhibition Hall
11h00
Round Table IV - Training 4.0: Impact of e-Learning and Artificial Intelligence
- Pasteur Auditorium
Chairman
10h00
Training 4.0: Impact of e-Learning and Artificial Intelligence
12h30
Lunch at the Exhibition Hall
14h00
Breakthrough Innovations in Bioproduction - Session II
- Descartes Auditorium
Chairman
14h00
Molecular optical spectroscopy as a PAT tool in USP bioprocessing
Igor CHOURPA
Professor, Director of EA 6295 Nanomedicines and Nanoprobes, Director of the Analytical Chemistry Laboratory
University of Tours, France
14h10
Design and development of chemically defined media supplemented with vegetable protein hydrolysates to enhance CHO cell growth and monoclonal antibody production
Fabien COMPEAU
Doctoral Researcher
Université Sorbonne Paris Nord, France
14h30
The Solution Molecular Microscope gives you more thoughts about biopharmaceuticals
Hiroyuki KANDA
Global Product Leader
Rigaku Corporation, Japan
14h50
iGEM: Sparking Innovation Pipeline from Training to Startup
Dorothy ZHANG
Vice President of Global Development
iGEM, France
15h00
Advancements and Perspectives in Bioproduction: Insights from Leading Experts of the Field
- Descartes Auditorium
Chairman
10h00
The Biotherapies and Bioproduction of Innovative Therapies Research Program (PEPR): How can we support the academic community?
Fanny CAPUTO
Comité de pilotage du PEPR Biothérapies
CEA Paris-Saclay, France
10h00
CIG A3P Biotherapy Processes - Update on Technical Guide: How to optimize the development and industrialization of your Biotherapy Product
Marie CECILLE
Head of CMC Leaders
Merck Life Science, France
10h30
Titre de la présentation
Géry VAN VYNCHT
Scientific Director
Quality Assistance, Belgium
10h30
How to select your CDMO? Insights from France Biotech’s biomanufacturing committee
Jérôme GABARD
Founder & CEO
BioMaje, France
Frédéric DESDOUITS
CEO
TreeFrog Therapeutics, France
Marc-Olivier MIGNON
Chief Commercial Officer
CELLforCURE by Seqens, France
Alain SAINSOT
CEO
GTP Bioways, France
16h20
Closing Keynote Lecture
- Descartes Auditorium
Chairman
10h00
The Drug Cell - Projet Important d’Intérêt Européen Commun (PIIEC), Med4Cure
Frédéric DEHAUT
National Director of Biology, Therapeutics and Diagnostics
Etablissement Français du Sang (EFS), France
10h30
Titre de la présentation
Hervé DE MALLIARD
Chairman
MGA Technologies, France
16h40
Closing remarks
17h00
